← Eichor
Study identifier: NCT06388174 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Idiopathic Generalized Epilepsy Syndromes

Condition: Epilepsy · Epilepsy, Idiopathic Generalized  ·  Sponsor: Shen Chun-Hong

PhaseN/A
Planned participants200
Who can joinAll sexes, 4 Years to 40 Years
Healthy volunteersNo

About this study

The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of anti-seizure medications (ASMs), and provides prognostic guidance. According to the new ILAE definition in 2022, the study aims to describe the clinical features, electroencephalographic, imaging findings and long-term prognosis.

This description comes directly from the study's public registry record.

Talk to the study team

Chunhong Shen  ·  +86 0571 87783872  ·  shen_neurology@zju.edu.cn

Always discuss trial participation with your own doctor first.

Locations (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University, ChinaHangzhou, Zhejiang, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06388174